Comparative pharmacology of the thyroid hormones
- PMID: 8333794
- DOI: 10.1016/0003-4975(93)90548-v
Comparative pharmacology of the thyroid hormones
Abstract
The thyroid hormones tetraiodothyronine and triiodothyronine (T3) are involved in a variety of biologic mechanisms. Thyroid hormones regulate protein, lipid, and carbohydrate anabolism and improve oxygen consumption in almost all body tissues. Thyroid hormone is formed by coupling of iodinated tyrosine molecules in the thyroid gland. Tetraiodothyronine is converted to T3, the active thyroid hormone. Drugs, disease states that induce severe physiologic stress, and surgical conditions (eg, cardiopulmonary bypass) can alter the levels of circulating active hormone by interfering with the peripheral conversion of tetraiodothyronine to T3. This low T3 ("euthyroid sick syndrome") state is manifested by low circulating levels of T3 and hemodynamic abnormalities. Active thyroid hormone replacement with T3, because of its pharmacologic actions, may be an ideal therapy in these conditions.
Similar articles
-
[Low T3 syndrome].Rev Prat. 1998 Nov 15;48(18):2018-22. Rev Prat. 1998. PMID: 9881012 French.
-
Euthyroid sick syndrome: an overview.Thyroid. 1997 Feb;7(1):125-32. doi: 10.1089/thy.1997.7.125. Thyroid. 1997. PMID: 9086580 Review.
-
[Euthyroid sick syndrome: an important clinical problem].Wiad Lek. 2017;70(2 pt 2):376-385. Wiad Lek. 2017. PMID: 29059662 Review. Polish.
-
Euthyroid Sick Syndrome.Compr Physiol. 2016 Mar 15;6(2):1071-80. doi: 10.1002/cphy.c150017. Compr Physiol. 2016. PMID: 27065175 Review.
-
Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome".Ann Thorac Surg. 1991 Jul;52(1):46-50. doi: 10.1016/0003-4975(91)91416-s. Ann Thorac Surg. 1991. PMID: 2069461
Cited by
-
Prediction of infarct severity from triiodothyronine levels in patients with ST-elevation myocardial infarction.Korean J Intern Med. 2014 Jul;29(4):454-65. doi: 10.3904/kjim.2014.29.4.454. Epub 2014 Jun 27. Korean J Intern Med. 2014. PMID: 25045293 Free PMC article.
-
Iatrogenic thyrotoxicosis secondary to compounded liothyronine.Can J Hosp Pharm. 2015 Jan-Feb;68(1):57-9. doi: 10.4212/cjhp.v68i1.1426. Can J Hosp Pharm. 2015. PMID: 25762821 Free PMC article. No abstract available.